Identification of tumor antigens and immune subtypes of acute myeloid leukemia for mRNA vaccine development

被引:4
作者
Wang, Fan [1 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Hematol, 1095 Jiefang Ave, Wuhan 430030, Hubei, Peoples R China
基金
中国国家自然科学基金;
关键词
mRNA vaccine; Acute myeloid leukemia; Tumor immune microenvironment; Tumor antigen; Cancer vaccination; OLDER PATIENTS; MYOFERLIN; SURVIVAL; OUTCOMES; PROTEIN; SLC9A9; PYRIN;
D O I
10.1007/s12094-023-03108-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundAcute myeloid leukemia (AML) is a highly aggressive hematological malignancy, and there has not been any significant improvement in therapy of AML over the past several decades. The mRNA vaccines have become a promising strategy against multiple cancers, however, its application on AML remains undefined. In this study, we aimed to identify novel antigens for developing mRNA vaccines against AML and explore the immune landscape of AML to select appropriate patients for vaccination.MethodsGenomic data and gene mutation data were retrieved from TCGA, GEO and cBioPortal, respectively. GEPIA2 was used to analyze differentially expressed genes. The single cell RNA-seq database Tumor Immune Single-cell Hub (TISCH) was used to explore the association between the potential tumor antigens and the infiltrating immune cells in the bone marrow. Consensus clustering analysis was applied to identify distinct immune subtypes. The correlation between the abundance of antigen presenting cells and the expression level of antigens was evaluated using Spearman correlation analysis. The characteristics of the tumor immune microenvironment in each subtype were investigated based on single-sample gene set enrichment analysis.ResultsFive potential tumor antigens were identified for mRNA vaccine from the pool of overexpressed and mutated genes, including CDH23, LRP1, MEFV, MYOF and SLC9A9, which were associated with infiltration of antigen-presenting immune cells (APCs). AML patients were stratified into two immune subtypes Cluster1 (C1) and Cluster2 (C2), which were characterized by distinct molecular and clinical features. C1 subtype demonstrated an immune-hot and immunosuppressive phenotype, while the C1 subtype had an immune-cold phenotype. Furthermore, the two immune subtype showed remarkably different expression of immune checkpoints, immunogenic cell death modulators and human leukocyte antigens.ConclusionCDH23, LRP1, MEFV, MYOF and SLC9A9 were potential antigens for developing AML mRNA vaccine, and AML patients in immune subtype 1 were suitable for vaccination.
引用
收藏
页码:2204 / 2223
页数:20
相关论文
共 60 条
  • [1] Antitumor activity of CAR-T cells targeting the intracellular oncoprotein WT1 can be enhanced by vaccination
    Akahori, Yasushi
    Wang, Linan
    Yoneyama, Motohiro
    Seo, Naohiro
    Okumura, Satoshi
    Miyahara, Yoshihiro
    Amaishi, Yasunori
    Okamoto, Sachiko
    Mineno, Junichi
    Ikeda, Hiroaki
    Maki, Takehiro
    Fujiwara, Hiroshi
    Akatsuka, Yoshiki
    Kato, Takuma
    Shiku, Hiroshi
    [J]. BLOOD, 2018, 132 (11) : 1134 - 1145
  • [2] Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia
    Anguille, Sebastien
    Van de Velde, Ann L.
    Smits, Evelien L.
    Van Tendeloo, Viggo F.
    Juliusson, Gunnar
    Cools, Nathalie
    Nijs, Griet
    Stein, Barbara
    Lion, Eva
    Van Driessche, Ann
    Vandenbosch, Irma
    Verlinden, Anke
    Gadisseur, Alain P.
    Schroyens, Wilfried A.
    Muylle, Ludo
    Vermeulen, Katrien
    Maes, Marie-Berthe
    Deiteren, Kathleen
    Malfait, Ronald
    Gostick, Emma
    Lammens, Martin
    Couttenye, Marie M.
    Jorens, Philippe
    Goossens, Herman
    Price, David A.
    Ladell, Kristin
    Oka, Yoshihiro
    Fujiki, Fumihiro
    Oji, Yusuke
    Sugiyama, Haruo
    Berneman, Zwi N.
    [J]. BLOOD, 2017, 130 (15) : 1713 - 1721
  • [3] Cadherin-23 Mediates Heterotypic Cell-Cell Adhesion between Breast Cancer Epithelial Cells and Fibroblasts
    Apostolopoulou, Maria
    Ligon, Lee
    [J]. PLOS ONE, 2012, 7 (03):
  • [4] Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
    Baden, Lindsey R.
    El Sahly, Hana M.
    Essink, Brandon
    Kotloff, Karen
    Frey, Sharon
    Novak, Rick
    Diemert, David
    Spector, Stephen A.
    Rouphael, Nadine
    Creech, C. Buddy
    McGettigan, John
    Khetan, Shishir
    Segall, Nathan
    Solis, Joel
    Brosz, Adam
    Fierro, Carlos
    Schwartz, Howard
    Neuzil, Kathleen
    Corey, Larry
    Gilbert, Peter
    Janes, Holly
    Follmann, Dean
    Marovich, Mary
    Mascola, John
    Polakowski, Laura
    Ledgerwood, Julie
    Graham, Barney S.
    Bennett, Hamilton
    Pajon, Rolando
    Knightly, Conor
    Leav, Brett
    Deng, Weiping
    Zhou, Honghong
    Han, Shu
    Ivarsson, Melanie
    Miller, Jacqueline
    Zaks, Tal
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (05) : 403 - 416
  • [5] The clinical progress of mRNA vaccines and immunotherapies
    Barbier, Ann J.
    Jiang, Allen Yujie
    Zhang, Peng
    Wooster, Richard
    Anderson, Daniel G.
    [J]. NATURE BIOTECHNOLOGY, 2022, 40 (06) : 840 - 854
  • [6] Vaccination Therapy for Acute Myeloid Leukemia: Where Do We Stand?
    Barbullushi, Kordelia
    Rampi, Nicolo
    Serpenti, Fabio
    Sciume, Mariarita
    Fabris, Sonia
    De Roberto, Pasquale
    Fracchiolla, Nicola Stefano
    [J]. CANCERS, 2022, 14 (12)
  • [7] Therapeutic Targeting of the Tumor Microenvironment
    Bejarano, Leire
    Jordao, Marta J. C.
    Joyce, Johanna A.
    [J]. CANCER DISCOVERY, 2021, 11 (04) : 933 - 959
  • [8] Low-density-lipoprotein-receptor-related protein 1 mediates Notch pathway activation
    Bian, Weixiang
    Tang, Mengfan
    Jiang, Hua
    Xu, Wenyan
    Hao, Wanyu
    Sui, Yue
    Hou, Yingnan
    Nie, Litong
    Zhang, Huimin
    Wang, Chao
    Li, Nan
    Wang, Jiadong
    Qin, Jun
    Wu, Lianfeng
    Ma, Xianjue
    Chen, Junjie
    Wang, Wenqi
    Li, Xu
    [J]. DEVELOPMENTAL CELL, 2021, 56 (20) : 2902 - +
  • [9] Advances in the development of personalized neoantigen-based therapeutic cancer vaccines
    Blass, Eryn
    Ott, Patrick A.
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2021, 18 (04) : 215 - 229
  • [10] Genomics of Acute Myeloid Leukemia Diagnosis and Pathways
    Bullinger, Lars
    Doehner, Konstanze
    Doehner, Hartmut
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (09) : 934 - 946